Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level

por Xianjing Hu, Sarwat Fatima, Minting Chen, Tao Huang, Yuen Wa Chen, Ruihong Gong, Hoi Leong Xavier Wong, Rongmin Yu, Liyan Song, Hiu Yee Kwan, Zhaoxiang Bian
Publicado 2021